BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 2524527)

  • 1. Retention of ligand binding activity by the extracellular domain of the IL-1 receptor.
    Dower SK; Wignall JM; Schooley K; McMahan CJ; Jackson JL; Prickett KS; Lupton S; Cosman D; Sims JE
    J Immunol; 1989 Jun; 142(12):4314-20. PubMed ID: 2524527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells.
    Kilian PL; Kaffka KL; Stern AS; Woehle D; Benjamin WR; Dechiara TM; Gubler U; Farrar JJ; Mizel SB; Lomedico PT
    J Immunol; 1986 Jun; 136(12):4509-14. PubMed ID: 2940296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene transfer of type 1 interleukin-1 receptor extracellular-domain complementary DNA into rabbit synovial cell line HIG-82 results in cellular blockade of interleukin-1 signal transduction.
    Mehraban F; Kasturi S
    Arthritis Rheum; 1998 Mar; 41(3):515-24. PubMed ID: 9506580
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-1 induces rapid phosphorylation of the IL-1 receptor.
    Gallis B; Prickett KS; Jackson J; Slack J; Schooley K; Sims JE; Dower SK
    J Immunol; 1989 Nov; 143(10):3235-40. PubMed ID: 2530274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the murine interleukin-1 receptor.
    Bird TA; Gearing AJ; Saklatvala J
    Dev Biol Stand; 1988; 69():83-91. PubMed ID: 2976006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin-1 binding, internalization, and processing in a murine osteoblastic cell line, MC3T3.E1.
    Shelly JA; Laborde AL
    Eur Cytokine Netw; 1992; 3(5):469-75. PubMed ID: 1477298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interleukin-1 stimulates the expression of type I and type II interleukin-1 receptors in the rat insulinoma cell line Rinm5F; sequencing a rat type II interleukin-1 receptor cDNA.
    Bristulf J; Gatti S; Malinowsky D; Bjork L; Sundgren AK; Bartfai T
    Eur Cytokine Netw; 1994; 5(3):319-30. PubMed ID: 7524717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A soluble interleukin 2 receptor produced by a normal alloreactive human T cell clone binds interleukin 2 with low affinity.
    Jacques Y; Le Mauff B; Boeffard F; Godard A; Soulillou JP
    J Immunol; 1987 Oct; 139(7):2308-16. PubMed ID: 2821110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation of soluble murine IL-6 receptor and anti-murine IL-6 receptor antibodies.
    Saito T; Yasukawa K; Suzuki H; Futatsugi K; Fukunaga T; Yokomizo C; Koishihara Y; Fukui H; Ohsugi Y; Yawata H
    J Immunol; 1991 Jul; 147(1):168-73. PubMed ID: 2051018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoclonal antibodies reacting with the interleukin 1 receptor define a multi-molecular complex.
    Lewis C; Mazzei G; Shaw A
    Eur J Immunol; 1990 Jan; 20(1):207-13. PubMed ID: 2137781
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detergent solubilization of the interleukin 1 receptor.
    Paganelli KA; Stern AS; Kilian PL
    J Immunol; 1987 Apr; 138(7):2249-53. PubMed ID: 2951435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of interleukin 1 receptors on human peripheral T cells.
    Shirakawa F; Tanaka Y; Ota T; Suzuki H; Eto S; Yamashita U
    J Immunol; 1987 Jun; 138(12):4243-8. PubMed ID: 2953802
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Properties of a specific interleukin 1 (IL 1) receptor on human Epstein Barr virus-transformed B lymphocytes: identity of the receptor for IL 1-alpha and IL 1-beta.
    Matsushima K; Akahoshi T; Yamada M; Furutani Y; Oppenheim JJ
    J Immunol; 1986 Jun; 136(12):4496-502. PubMed ID: 3011895
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The human IL-11 receptor requires gp130 for signalling: demonstration by molecular cloning of the receptor.
    Nandurkar HH; Hilton DJ; Nathan P; Willson T; Nicola N; Begley CG
    Oncogene; 1996 Feb; 12(3):585-93. PubMed ID: 8637716
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and detection of naturally occurring antibodies against IL-1 alpha and IL-1 beta in normal human plasma.
    Gallay P; Mach JP; Carrel S
    Eur Cytokine Netw; 1991; 2(5):329-38. PubMed ID: 1839507
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of murine IL-1 beta. Isolation, expression, and purification.
    Huang JJ; Newton RC; Rutledge SJ; Horuk R; Matthew JB; Covington M; Lin Y
    J Immunol; 1988 Jun; 140(11):3838-43. PubMed ID: 2967326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies to domains II and III of the IL-1 receptor accessory protein inhibit IL-1 beta activity but not binding: regulation of IL-1 responses is via type I receptor, not the accessory protein.
    Yoon DY; Dinarello CA
    J Immunol; 1998 Apr; 160(7):3170-9. PubMed ID: 9531272
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids.
    Arend WP; Malyak M; Smith MF; Whisenand TD; Slack JL; Sims JE; Giri JG; Dower SK
    J Immunol; 1994 Nov; 153(10):4766-74. PubMed ID: 7963543
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IL-1 and its receptor are translocated to the nucleus.
    Curtis BM; Widmer MB; deRoos P; Qwarnstrom EE
    J Immunol; 1990 Feb; 144(4):1295-303. PubMed ID: 2137488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression in Escherichia coli of fully active recombinant human IL 1 beta: comparison with native human IL 1 beta.
    Tocci MJ; Hutchinson NI; Cameron PM; Kirk KE; Norman DJ; Chin J; Rupp EA; Limjuco GA; Bonilla-Argudo VM; Schmidt JA
    J Immunol; 1987 Feb; 138(4):1109-14. PubMed ID: 2949012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.